{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:42:49Z","timestamp":1791826969885,"version":"4.3.4"},"reference-count":43,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2022,8,1]]},"abstract":"<jats:sec id=\"ab-coi220023-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Diagnostic delays in breast cancer detection may be associated with later-stage disease and higher anxiety, but data on multilevel factors associated with diagnostic delay are limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-coi220023-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate individual-, neighborhood-, and health care\u2013level factors associated with differences in time from abnormal screening to biopsy among racial and ethnic groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-coi220023-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This prospective cohort study used data from women aged 40 to 79 years who had abnormal results in screening mammograms conducted in 109 imaging facilities across 6 US states between 2009 and 2019. Data were analyzed from February 21 to November 4, 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-coi220023-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>Individual-level factors included self-reported race and ethnicity, age, family history of breast cancer, breast density, previous breast biopsy, and time since last mammogram; neighborhood-level factors included geocoded education and income based on residential zip codes and rurality; and health care\u2013level factors included mammogram modality, screening facility academic affiliation, and facility onsite biopsy service availability. Data were also assessed by examination year.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-coi220023-8\">\n                    <jats:title>Main Outcome and Measures<\/jats:title>\n                    <jats:p>The main outcome was unadjusted and adjusted relative risk (RR) of no biopsy within 30, 60, and 90 days using sequential log-binomial regression models. A secondary outcome was unadjusted and adjusted median time to biopsy using accelerated failure time models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-coi220023-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 45\u202f186 women (median [IQR] age at screening, 56 [48-65] years) with 46\u202f185 screening mammograms with abnormal results were included. Of screening mammograms with abnormal results recommended for biopsy, 15\u202f969 (34.6%) were not resolved within 30 days, 7493 (16.2%) were not resolved within 60 days, and 5634 (12.2%) were not resolved within 90 days. Compared with White women, there was increased risk of no biopsy within 30 and 60 days for Asian (30 days: RR, 1.66; 95% CI, 1.31-2.10; 60 days: RR, 1.58; 95% CI, 1.15-2.18), Black (30 days: RR, 1.52; 95% CI, 1.30-1.78; 60 days: 1.39; 95% CI, 1.22-1.60), and Hispanic (30 days: RR, 1.50; 95% CI, 1.24-1.81; 60 days: 1.38; 95% CI, 1.11-1.71) women; however, the unadjusted risk of no biopsy within 90 days only persisted significantly for Black women (RR, 1.28; 95% CI, 1.11-1.47). Sequential adjustment for selected individual-, neighborhood-, and health care\u2013level factors, exclusive of screening facility, did not substantially change the risk of no biopsy within 90 days for Black women (RR, 1.27; 95% CI, 1.12-1.44). After additionally adjusting for screening facility, the increased risk for Black women persisted but showed a modest decrease (RR, 1.20; 95% CI, 1.08-1.34).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-coi220023-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this cohort study involving a diverse cohort of US women recommended for biopsy after abnormal results on screening mammography, Black women were the most likely to experience delays to diagnostic resolution after adjusting for multilevel factors. These results suggest that adjustment for multilevel factors did not entirely account for differences in time to breast biopsy, but unmeasured factors, such as systemic racism and other health care system factors, may impact timely diagnosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaoncol.2022.1990","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T11:33:57Z","timestamp":1655984037000},"page":"1115","source":"Crossref","is-referenced-by-count":80,"title":["Multilevel Factors Associated With Time to Biopsy After Abnormal Screening Mammography Results by Race and Ethnicity"],"prefix":"10.1001","volume":"8","author":[{"given":"Marissa B.","family":"Lawson","sequence":"first","affiliation":[{"name":"Department of Radiology, University of Washington School of Medicine, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C. S.","family":"Bissell","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Department of Public Health Sciences, University of California Davis School of Medicine, Davis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana L.","family":"Miglioretti","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Department of Public Health Sciences, University of California Davis School of Medicine, Davis"},{"name":"Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Eavey","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina H.","family":"Chapman","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Michigan Medicine, Ann Arbor"},{"name":"University of Wisconsin\u2013Madison School of Medicine and Public Health, Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne S.","family":"Mandelblatt","sequence":"additional","affiliation":[{"name":"Department of Oncology, Cancer Prevention and Control Program, Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Onega","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, University of Utah, Huntsman Cancer Institute, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise M.","family":"Henderson","sequence":"additional","affiliation":[{"name":"Departments of Radiology and Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garth H.","family":"Rauscher","sequence":"additional","affiliation":[{"name":"Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Kerlikowske","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Epidemiology and Biostatistics, University of California, San Francisco"},{"name":"General Internal Medicine Section, Department of Veterans Affairs, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian L.","family":"Sprague","sequence":"additional","affiliation":[{"name":"Departments of Surgery and Radiology, University of Vermont Cancer Center, University of Vermont, Burlington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin J. A.","family":"Bowles","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte C.","family":"Gard","sequence":"additional","affiliation":[{"name":"Department of Economics, Applied Statistics, and International Business, New Mexico State University, Las Cruces"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Parsian","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph I.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Washington School of Medicine, Seattle"},{"name":"Department of Health Services, University of Washington School of Public Health, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"15","key":"coi220023r1","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1002\/cncr.v121.15","article-title":"Effect of treatment and mammography detection on breast cancer survival over time: 1990-2007.","volume":"121","author":"Kaplan","year":"2015","journal-title":"Cancer"},{"issue":"17","key":"coi220023r2","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1056\/NEJMoa050518","article-title":"Effect of screening and adjuvant therapy on mortality from breast cancer.","volume":"353","author":"Berry","year":"2005","journal-title":"N Engl J Med"},{"issue":"4","key":"coi220023r3","doi-asserted-by":"publisher","first-page":"244","DOI":"10.7326\/M15-0969","article-title":"Effectiveness of breast cancer screening: systematic review and meta-analysis to update the 2009 U.S. Preventive Services Task Force Recommendation.","volume":"164","author":"Nelson","year":"2016","journal-title":"Ann Intern Med"},{"issue":"2","key":"coi220023r4","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1158\/1055-9965.EPI-17-0378","article-title":"Effect of time to diagnostic testing for breast, cervical, and colorectal cancer screening abnormalities on screening efficacy: a modeling study.","volume":"27","author":"Rutter","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"coi220023r5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1177\/096914130301100107","article-title":"Influence of abnormal screens on delays and prognostic indicators of screen-detected breast carcinoma.","volume":"11","author":"Ganry","year":"2004","journal-title":"J Med Screen"},{"issue":"8","key":"coi220023r6","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Influence of delay to diagnosis on prognostic indicators of screen-detected breast carcinoma.","volume":"94","author":"Olivotto","year":"2002","journal-title":"Cancer"},{"issue":"5","key":"coi220023r7","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1177\/1359105315607828","article-title":"Anxiety prior to breast biopsy: relationships with length of time from breast biopsy recommendation to biopsy procedure and psychosocial factors.","volume":"22","author":"Hayes Balmadrid","year":"2017","journal-title":"J Health Psychol"},{"issue":"5","key":"coi220023r8","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0022-3999(03)00512-9","article-title":"Waiting for a breast biopsy: psychosocial consequences and coping strategies.","volume":"55","author":"Lebel","year":"2003","journal-title":"J Psychosom Res"},{"issue":"4","key":"coi220023r9","doi-asserted-by":"publisher","first-page":"256","DOI":"10.7326\/M15-0970","article-title":"Harms of breast cancer screening: systematic review to update the 2009 U.S. Preventive Services Task Force recommendation.","volume":"164","author":"Nelson","year":"2016","journal-title":"Ann Intern Med"},{"issue":"20","key":"coi220023r10","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1001\/archinte.166.20.2244","article-title":"Delays in breast cancer diagnosis and treatment by racial\/ethnic group.","volume":"166","author":"Gorin","year":"2006","journal-title":"Arch Intern Med"},{"issue":"6","key":"coi220023r11","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.whi.2016.09.003","article-title":"Time from screening mammography to biopsy and from biopsy to breast cancer treatment among Black and White, women Medicare beneficiaries not participating in a health maintenance organization.","volume":"26","author":"Selove","year":"2016","journal-title":"Womens Health Issues"},{"issue":"3","key":"coi220023r12","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1377\/hlthaff.2018.05026","article-title":"Vulnerable and less vulnerable women in high-deductible health plans experienced delayed breast cancer care.","volume":"38","author":"Wharam","year":"2019","journal-title":"Health Aff (Millwood)"},{"issue":"11","key":"coi220023r13","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1158\/1055-9965.EPI-16-0148","article-title":"Insurance-based differences in time to diagnostic follow-up after positive screening mammography.","volume":"25","author":"Durham","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"coi220023r14","first-page":"162","article-title":"Timing of follow-up after abnormal screening and diagnostic mammograms.","volume":"17","author":"Wernli","year":"2011","journal-title":"Am J Manag Care"},{"issue":"18","key":"coi220023r15","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.1002\/cncr.v123.18","article-title":"Disparities in abnormal mammogram follow-up time for Asian women compared with non-Hispanic white women and between Asian ethnic groups.","volume":"123","author":"Nguyen","year":"2017","journal-title":"Cancer"},{"issue":"3","key":"coi220023r16","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s10549-012-2304-1","article-title":"Time to diagnosis and breast cancer stage by race\/ethnicity.","volume":"136","author":"Warner","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"coi220023r17","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.1245\/s10434-020-08484-9","article-title":"The waiting game: how long are breast cancer patients waiting for definitive diagnosis?","volume":"27","author":"Kovar","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"coi220023r18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/00005650-200502000-00007","article-title":"Racial inequities in the timing of breast cancer detection, diagnosis, and initiation of treatment.","volume":"43","author":"Elmore","year":"2005","journal-title":"Med Care"},{"issue":"S1","key":"coi220023r19","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.2105\/AJPH.2018.304883","article-title":"The National Institute on Minority Health and Health Disparities Research Framework.","volume":"109","author":"Alvidrez","year":"2019","journal-title":"Am J Public Health"},{"issue":"4","key":"coi220023r20","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/MLR.0b013e318280f04c","article-title":"Timeliness of abnormal screening and diagnostic mammography follow-up at facilities serving vulnerable women.","volume":"51","author":"Goldman","year":"2013","journal-title":"Med Care"},{"issue":"10","key":"coi220023r21","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1097\/MLR.0000000000000417","article-title":"Racial\/ethnic disparities in time to a breast cancer diagnosis: the mediating effects of health care facility factors.","volume":"53","author":"Molina","year":"2015","journal-title":"Med Care"},{"issue":"4","key":"coi220023r22","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/cncr.v116:4","article-title":"Predictors of timely follow-up after abnormal cancer screening among women seeking care at urban community health centers.","volume":"116","author":"Battaglia","year":"2010","journal-title":"Cancer"},{"issue":"16","key":"coi220023r23","doi-asserted-by":"publisher","first-page":"3824","DOI":"10.1002\/cncr.25970","article-title":"Having health insurance does not eliminate race\/ethnicity-associated delays in breast cancer diagnosis in the District of Columbia.","volume":"117","author":"Hoffman","year":"2011","journal-title":"Cancer"},{"issue":"1","key":"coi220023r24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1148\/radiol.2016161174","article-title":"National performance benchmarks for modern screening digital mammography: update from the Breast Cancer Surveillance Consortium.","volume":"283","author":"Lehman","year":"2017","journal-title":"Radiology"},{"issue":"1","key":"coi220023r26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1148\/radiol.2017161519","article-title":"National performance benchmarks for modern diagnostic digital mammography: update from the Breast Cancer Surveillance Consortium.","volume":"283","author":"Sprague","year":"2017","journal-title":"Radiology"},{"issue":"4","key":"coi220023r27","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.2214\/ajr.169.4.9308451","article-title":"Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database.","volume":"169","author":"Ballard-Barbash","year":"1997","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"coi220023r30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1742-7622-10-14","article-title":"Log-binomial models: exploring failed convergence.","volume":"10","author":"Williamson","year":"2013","journal-title":"Emerg Themes Epidemiol"},{"issue":"7","key":"coi220023r31","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified Poisson regression approach to prospective studies with binary data.","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"issue":"5","key":"coi220023r32","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1093\/ije\/dyt127","article-title":"Mediation analysis in epidemiology: methods, interpretation and bias.","volume":"42","author":"Richiardi","year":"2013","journal-title":"Int J Epidemiol"},{"issue":"10","key":"coi220023r34","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1007\/s11606-020-05972-2","article-title":"Organization communication factors and abnormal mammogram follow-up: a qualitative study among ethnically diverse women across three healthcare systems.","volume":"35","author":"Kenny","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"2","key":"coi220023r35","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1377\/hlthaff.2021.01466","article-title":"Structural racism in historical and modern US health care policy.","volume":"41","author":"Yearby","year":"2022","journal-title":"Health Aff (Millwood)"},{"issue":"10077","key":"coi220023r36","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(17)30569-X","article-title":"Structural racism and health inequities in the USA: evidence and interventions.","volume":"389","author":"Bailey","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"coi220023r37","doi-asserted-by":"publisher","first-page":"270","DOI":"10.2214\/AJR.21.26597","article-title":"Disparities in same-day diagnostic imaging in breast cancer screening: impact of an immediate-read screening mammography program implemented during the COVID-19 pandemic.","volume":"218","author":"Dontchos","year":"2022","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"coi220023r38","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1177\/1524839918782168","article-title":"A comparison of different intensities of patient navigation after abnormal mammography.","volume":"20","author":"Glassgow","year":"2019","journal-title":"Health Promot Pract"},{"issue":"11","key":"coi220023r39","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1016\/j.jacr.2019.05.011","article-title":"Impact of a same-day breast biopsy program on disparities in time to biopsy.","volume":"16","author":"Dontchos","year":"2019","journal-title":"J Am Coll Radiol"},{"issue":"9","key":"coi220023r40","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1093\/jnci\/djab045","article-title":"Changes in mammography use by women\u2019s characteristics during the first 5 months of the COVID-19 pandemic.","volume":"113","author":"Sprague","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"coi220023r41","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jacr.2021.09.023","article-title":"Rationing and disparities in health care: implications for radiology clinical practice guidelines.","volume":"19","author":"Brown","year":"2022","journal-title":"J Am Coll Radiol"},{"issue":"5","key":"coi220023r42","doi-asserted-by":"publisher","first-page":"527","DOI":"10.6004\/jnccn.2016.0061","article-title":"Fine-needle aspiration biopsy of palpable breast masses: patterns of clinical use and patient experience.","volume":"14","author":"Ly","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"issue":"8","key":"coi220023r43","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.jacr.2020.02.015","article-title":"Trends in the use of percutaneous versus open surgical breast biopsy: an update.","volume":"17","author":"Teberian","year":"2020","journal-title":"J Am Coll Radiol"},{"key":"coi220023r28","volume-title":"ACR BI-RADS Atlas, Breast Imaging Reporting and Data System","author":"Sickles","year":"2013"},{"key":"coi220023r33","doi-asserted-by":"crossref","first-page":"xvi","DOI":"10.1201\/9780429246593","volume-title":"An Introduction to the Bootstrap","author":"Efron","year":"1994"},{"key":"coi220023r25","unstructured":"Breast Cancer Surveillance Consortium. Accessed May 19, 2022. https:\/\/www.bcsc-research.org"},{"key":"coi220023r29","unstructured":"Breast Cancer Surveillance Consortium. BCSC standard definitions, version 3. Accessed November 20, 2021. https:\/\/www.bcsc-research.org\/application\/files\/6916\/1429\/6964\/BCSC_Data_Definitions_v3__2020.09.23.pdf"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2793713\/jamaoncology_lawson_2022_oi_220023_1660581528.14683.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T11:17:05Z","timestamp":1660821425000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2793713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,1]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2022.1990","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,1]]}}}